Pfizer (PFE) PT Lowered to $44 at Barclays
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $26.87 --0%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Pfizer (NYSE: PFE) to $44.00 (from $50.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- Ceribell (CBLL) PT Raised to $30 at BTIG
- Citi Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
